炎症性乳腺癌和化学免疫治疗的过渡性完整放射反应:一个案例报告
Adina Amin1, Sasis Sirikanjanapong2, Amardeep Kalsi1,3
1Department of Internal Medicine, New York-Presbyterian Brooklyn Methodist Hospital Brooklyn, Brooklyn, NY, USA.
Case reports in oncology
|October 30, 2024
概括
炎症性乳腺癌是具有侵略性的. 在转移的三阴性病例中,布罗利祖马布与化疗显示出短暂的反应,突出显示了尽管治疗的生存率很差.
科学领域:
- 在瘤学瘤学.
- 免疫治疗是一种免疫疗法.
- 乳腺癌研究研究 乳腺癌研究
背景情况:
- 炎症性乳腺癌 (IBC) 是一种罕见的,具有较差生存率的侵袭性亚型.
- 转移性IBC具有高的淋巴结参与率和远程转移.
- 布罗利祖马布已批准用于早期和晚期三阴性乳腺癌 (TNBC),基于PD-L1状态.
更多相关视频
08:29Ex Vivo Treatment Response of Primary Tumors and/or Associated Metastases for Preclinical and Clinical Development of Therapeutics
Published on: October 2, 2014
14.7K
11:02Induction of Invasive Transitional Cell Bladder Carcinoma in Immune Intact Human MUC1 Transgenic Mice: A Model for Immunotherapy Development
Published on: October 30, 2013
21.2K
